179 related articles for article (PubMed ID: 38783901)
1. DIPAN: Detecting personalized intronic polyadenylation derived neoantigens from RNA sequencing data.
Liu X; Jin W; Bao D; He T; Wang W; Li Z; Yang X; Tong Y; Shu M; Wang Y; Yuan J; Yang Y
Comput Struct Biotechnol J; 2024 Dec; 23():2057-2066. PubMed ID: 38783901
[TBL] [Abstract][Full Text] [Related]
2. InPACT: a computational method for accurate characterization of intronic polyadenylation from RNA sequencing data.
Liu X; Chen H; Li Z; Yang X; Jin W; Wang Y; Zheng J; Li L; Xuan C; Yuan J; Yang Y
Nat Commun; 2024 Mar; 15(1):2583. PubMed ID: 38519498
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated dynamics and potential regulators of intronic polyadenylation revealed by IPAFinder using standard RNA-seq data.
Zhao Z; Xu Q; Wei R; Wang W; Ding D; Yang Y; Yao J; Zhang L; Hu YQ; Wei G; Ni T
Genome Res; 2021 Nov; 31(11):2095-2106. PubMed ID: 34475268
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
Shi Y; Jing B; Xi R
Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory polarization and colorectal cancer modulate alternative and intronic polyadenylation in primary human macrophages.
Wilton J; de Mendonça FL; Pereira-Castro I; Tellier M; Nojima T; Costa AM; Freitas J; Murphy S; Oliveira MJ; Proudfoot NJ; Moreira A
Front Immunol; 2023; 14():1182525. PubMed ID: 37359548
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers.
Zhao Z; Xu Q; Wei R; Huang L; Wang W; Wei G; Ni T
Nucleic Acids Res; 2021 Oct; 49(18):10369-10381. PubMed ID: 34508351
[TBL] [Abstract][Full Text] [Related]
7. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
Zhang X; Qi Y; Zhang Q; Liu W
Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
[TBL] [Abstract][Full Text] [Related]
8. Widespread intronic polyadenylation diversifies immune cell transcriptomes.
Singh I; Lee SH; Sperling AS; Samur MK; Tai YT; Fulciniti M; Munshi NC; Mayr C; Leslie CS
Nat Commun; 2018 Apr; 9(1):1716. PubMed ID: 29712909
[TBL] [Abstract][Full Text] [Related]
9. The landscape and clinical relevance of intronic polyadenylation in human cancers.
Cheng X; Jiang G; Zhou X; Wang J; Zhao Z; Zhang J; Ni T
J Genet Genomics; 2024 May; ():. PubMed ID: 38740258
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.
Wickland DP; McNinch C; Jessen E; Necela B; Shreeder B; Lin Y; Knutson KL; Asmann YW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754917
[TBL] [Abstract][Full Text] [Related]
11. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
Borden ES; Buetow KH; Wilson MA; Hastings KT
Front Oncol; 2022; 12():836821. PubMed ID: 35311072
[TBL] [Abstract][Full Text] [Related]
12. Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα.
Elton TS; Hernandez VA; Carvajal-Moreno J; Wang X; Ipinmoroti D; Yalowich JC
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804920
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome sequencing suggests that pre-mRNA splicing counteracts widespread intronic cleavage and polyadenylation.
Vlasenok M; Margasyuk S; Pervouchine DD
NAR Genom Bioinform; 2023 Jun; 5(2):lqad051. PubMed ID: 37260513
[TBL] [Abstract][Full Text] [Related]
14. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
15. Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy.
Li G; Mahajan S; Ma S; Jeffery ED; Zhang X; Bhattacharjee A; Venkatasubramanian M; Weirauch MT; Miraldi ER; Grimes HL; Sheynkman GM; Tilburgs T; Salomonis N
Sci Transl Med; 2024 Jan; 16(730):eade2886. PubMed ID: 38232136
[TBL] [Abstract][Full Text] [Related]
16.
Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
[TBL] [Abstract][Full Text] [Related]
17. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
[TBL] [Abstract][Full Text] [Related]
18. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
[TBL] [Abstract][Full Text] [Related]
19. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer.
Brito Baleeiro R; Liu P; Chard Dunmall LS; Di Gioia C; Nagano A; Cutmore L; Wang J; Chelala C; Nyambura LW; Walden P; Lemoine N; Wang Y
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586771
[TBL] [Abstract][Full Text] [Related]
20. Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration.
Chen X; Lloyd SM; Kweon J; Gamalong GM; Bao X
Nat Commun; 2021 Jan; 12(1):448. PubMed ID: 33469008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
